Marijuana --Dementia, bad- Epileptics, good? Marijuana

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
143
Marijuana --Dementia, bad- Epileptics, good?

Marijuana found to reduce blood flow to the brain: Study authors suggest this may increase risk of dementia, but this effect also makes it medicinally useful for epileptics

https://www.alternativemedicine.news/2019-04-...ptics.html

Scientific literature regarding the effects of marijuana currently has been expanding. This has resulted in a plethora of studies, mainly how marijuana can affect the brain. While earlier studies have shown that it can help with treatment of brain-related disorders such as epilepsy, more recent tests not indicate that marijuana lowers blood circulation to some areas of the brain, which are essential for memory development.

According to the results of a recent, large-scale brain imaging study, marijuana users receive lower blood flow to the brain, including the hippocampus, which is essential for memory function and is known to be hit by Alzheimer’s. Using single photon emission computed tomography (SPECT), an advanced imaging tool that observes blood flow and movement patterns, researchers were able to determine abnormally low blood flow levels of persons who used marijuana compared to those who didn’t.

Data used for the research were pooled from a massive multi-site database, which contains at least 27,000 cases that were evaluated in nine clinics across the U.S. between 1995 to 2015. From this, researchers sampled 982 patients who had either previously used or were currently using marijuana. Users were analyzed using a brain SPECT and by conducting mental concentration tests against a sample of 100 people who had not used marijuana to determine whether there were significant differences that arose between users and non-users of cannabis.

The results yielded that people who had used marijuana were identified in their brain scans by a low blood flow through their right hippocampus, which is responsible for storing memory.

“What struck me was not only the global reduction in blood flow in the marijuana users’ brains but that the hippocampus was the most affected region due to its role in memory and Alzheimer’s disease,” according to Dr. Lantie Jorandby, one of the co-authors of the study. “This work suggests that marijuana use had damaging influences in the brain – particularly regions important in memory and learning and known to be affected by Alzheimer’s.”

Previous studies have indicated that the hippocampus physically shrinks with marijuana use; however, researchers noted that no review has checked out perfusion in a group this big. Also, they said that only a few studies that look at the impact of the use of marijuana on the blood flow of the brain exist.

The results of the study contrast with other bodies of research indicated the benefits of marijuana in addressing neurological diseases – most notable of which is epilepsy. A study published in the New England Journal of Medicine has reported that cannabidiol (CBD), a nonpsychoactive ingredient in marijuana, can reduce the likelihood of epileptic seizures in children. (Related: Medical cannabis use found to dramatically decrease reliance on addictive prescription medications.)

“This study clearly establishes cannabidiol as an effective anti-seizure drug for this disorder and this age group,” according to lead investigator Orrin Devinsky of the Comprehensive Epilepsy Center at New York University Langone Medical Center. “It certainly deserves to be studied in other types of epilepsy.”

In the study, 120 children and teenagers who have Dravet syndrome, a rare form of epilepsy that is drug-resistant, were observed. The researchers found out that participants who were given CBD posted a significant reduction in the number of convulsive seizures experienced in a month. Moreover, 62 percent of the caregivers in the CBD group reported an improvement in their child’s overall state during the trials.

This evidence supports other studies made on the anticonvulsant properties of CBD. Researchers believe this is due to marijuana’s ability to block specific transporters, as well as its “neuroprotective and anti-inflammatory effects.” Results of this study showed that CBD might be a useful means to treat epilepsy and other disorders in the central nervous system – particularly when it comes to seizures and other comorbid conditions.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 272

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 238

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 12

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 315

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 286

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 83

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 110

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 183

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 0

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading

Top 5 Most Recently Viewed Articles

Anytime Fitness Launches First Club in Dubai, UAE, Expanding Reach

Updated Category News Views 508

Anytime Fitness Sets Foot in Dubai with Grand Opening The new club in the Arjan district signifies a vital expansion of fitness services to the United Arab Emirates; members benefit from personalized wellness plans, state-of-the-art Technogym equipment, and SmartCoaching services available through the AF App. Purpose Brands LLC has announced the grand opening of its very...

Continue Reading
Crescent Biopharma's Strategic Partnership and Market Moves

Updated Category News Views 196

Crescent Biopharma's Recent Stock Activity Crescent Biopharma, Inc. (NASDAQ: CBIO) has been experiencing a notable fluctuation in its stock value lately. Shares initially showed a positive trend, indicating investor optimism following their recent announcement, but later reversed course and began to dip slightly. This change in trading comes as the company unveiled a...

Continue Reading
Investors Alert: Legal Developments for Snap Inc. Shareholders

Updated Category News Views 167

Important Update for Snap Inc. Shareholders If you have invested in Snap Inc. (NYSE: SNAP) and purchased shares in 2021 or earlier, there are significant legal developments that you should be aware of. A recent lawsuit is reportedly pending, and the Shareholders Foundation has urged impacted investors to take action. Details of the Lawsuit Against Snap Inc. The lawsuit...

Continue Reading
Understanding the Influence of Trump's Fiscal Policies on Debt

Updated Category News Views 493

Understanding the Influence of Trump's Fiscal Policies on Debt When it comes to government debt, being large isn't necessarily an advantage. Recent fiscal policies introduced by the Trump administration, including tariffs and the initiatives of the Department of Government Efficiency, aim to address the growing fiscal deficit. However, the overall effect may result in...

Continue Reading
Analyzing Sea's Short Interest Trends and Market Implications

Updated Category News Views 128

Understanding Sea's Short Interest Dynamics Sea's short percent of float has notably increased by 5.22% since the latest report. The company currently has 21.99 million shares sold short, which accounts for 7.46% of its total shares available for trading. Based on recent trading volumes, it would take an average of 5.24 days for traders to cover their short positions....

Continue Reading